Zobrazeno 1 - 10
of 409
pro vyhledávání: '"Ben Tran"'
Autor:
Grace Y. Kim, Ciara Conduit, Sophie O’Haire, Chia Yuen Chong, Olivia Baenziger, Jeremy Lewin, Benjamin Thomas, Nathan Lawrentschuk, Martin R. Stockler, Ian Olver, Peter Grimison, Ben Tran
Publikováno v:
Basic and Clinical Andrology, Vol 34, Iss 1, Pp 1-7 (2024)
Abstract Background Primary hypogonadism is a recognised complication in survivors of testicular cancer. However, secondary hypogonadism can result from other causes that suppress the hypothalamic-pituitary axis, including obesity, high dose glucocor
Externí odkaz:
https://doaj.org/article/4470c15dd2794376bcc33c5df672da1c
Publikováno v:
Contemporary Clinical Trials Communications, Vol 37, Iss , Pp 101239- (2024)
The Ph1 oncology trial landscape is evolving in response to advances in understanding of cancer biology, novel drug discovery platforms, and therapeutic modalities. To uncover emerging trends in oncology drug development, we identified 7,061 solid tu
Externí odkaz:
https://doaj.org/article/1ccefd4999504a828c6c98564db484e9
Autor:
Ben Tran, Jenessa B Smith, Jason Wu, Mark Kennedy, Haixia Wang, Ines Mende, Kartoa Chow, Monica Kukreja, Zain Dibian, Elisa Ha, Tejon McRae, Tanya Nguyen, Tommy Saephan, Erin Clagett, Nathan Lang, Raymond Lim, Alice Chang, Liselle Guiang, Nadija Guner, Swetha Gunturu, Elizabeth Huang, Aditya Lalchandani, Max Lee, Sophia Phillips, Stephen Chang, Eric Chu, Ryan Zapata, En-Hsiang Chang, Rory Dai, Fadi Kandarian, Hayden Ko, Anton Nguyen, Wendy Nie, Kathan Parikh, Lindsay Rios, Xiangle Sun, Stella Tran, Peter Holman, Tim Sirichoke
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e085cc1d8892417d9b54f8ce75ba8096
Autor:
Hweixian Leong Penny, Kelly Hainline, Nathaniel Theoharis, Bin Wu, Christian Brandl, Christian Webhofer, Mason McComb, Sabine Wittemer-Rump, Gökben Koca, Sabine Stienen, Ralf C. Bargou, Horst-Dieter Hummel, Wolfgang Loidl, Carsten Grüllich, Tobias Eggert, Ben Tran, Daniel T. Mytych
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIn oncology, anti-drug antibody (ADA) development that significantly curtails response durability has not historically risen to a level of concern. The relevance and attention ascribed to ADAs in oncology clinical studies have therefore b
Externí odkaz:
https://doaj.org/article/212fa5cf8e9f4350b4b25e8f215a32d7
Autor:
Khic-Houy Prang, Bill Karanatsios, Angela Zhang, Ebony Verbunt, Hui-li Wong, Vanessa Wong, Lucy Gately, Ben Tran, Peter Gibbs, Margaret Kelaher
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background Randomised controlled trials (RCTs) are considered the “gold standard” for evaluating the effectiveness of interventions in clinical research. However, conventional RCTs are typically complex, expensive, and have narrow eligib
Externí odkaz:
https://doaj.org/article/1d6836d24e714fe2b00e3ba9b899434b
Autor:
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin, Ben Tran
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those who do not. 2-18fluo
Externí odkaz:
https://doaj.org/article/0eeadf1443534cc485a6cb545978a500
Autor:
Cristian Udovicich, Jason Callahan, Mathias Bressel, Wee Loon Ong, Marlon Perera, Ben Tran, Arun Azad, Shankar Haran, Daniel Moon, Sarat Chander, Mark Shaw, Renu Eapen, Jeremy Goad, Nathan Lawrentschuk, Declan G. Murphy, Michael Hofman, Shankar Siva
Publikováno v:
European Urology Open Science, Vol 44, Iss , Pp 60-68 (2022)
Background: Prostate-specific membrane antigen (PSMA) is overexpressed in the neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence regarding the use of PSMA positron emission tomography/computed tomography (PET/CT) in
Externí odkaz:
https://doaj.org/article/66976b2987cf4402b5e63b4c52c38980
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
The lack of success in prostate cancer from immune checkpoint inhibitors, which is likely multifactorial, has led to the development and investigation of a number of other novel immunotherapeutic techniques, including antibody–drug conjugates, T-ce
Externí odkaz:
https://doaj.org/article/daba7d43128241e8a1fc4ec465eee638
Autor:
Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M. Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran
Publikováno v:
BJUI Compass, Vol 3, Iss 3, Pp 205-213 (2022)
Abstract Introduction Several systemic therapies have demonstrated a survival advantage in metastatic castration resistant prostate cancer (mCRPC). Access to these medications varies significantly worldwide. In Australia until recently, patients must
Externí odkaz:
https://doaj.org/article/dc78be7e4b24417987370623f12358ff
Autor:
Blossom Mak, Hui-Ming Lin, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis, Kate Mahon, Martin R. Stockler, Karen Briscoe, Gavin Marx, Alison Zhang, Megan Crumbaker, Winston Tan, Kevin Huynh, Thomas G. Meikle, Natalie A. Mellett, Andrew J. Hoy, Pan Du, Jianjun Yu, Shidong Jia, Anthony M. Joshua, David J. Waugh, Lisa M. Butler, Manish Kohli, Peter J. Meikle, Arun A. Azad, Lisa G. Horvath
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background Both changes in circulating lipids represented by a validated poor prognostic 3-lipid signature (3LS) and somatic tumour genetic aberrations are individually associated with worse clinical outcomes in men with metastatic castratio
Externí odkaz:
https://doaj.org/article/0c49ff062a1c4a14adec64ab46d60c0a